Drug Shortage Report for OGIVRI
| Report ID | 120774 |
| Drug Identification Number | 02474433 |
| Brand name | OGIVRI |
| Common or Proper name | TRASTUZUMAB |
| Company Name | BIOSIMILAR COLLABORATIONS IRELAND LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TRASTUZUMAB WATER |
| Strength(s) | 440MG 20ML |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1VL TRASTUZUMAB 1VL BWFI |
| ATC code | L01XC |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-07-17 |
| Estimated end date | 2020-08-04 |
| Actual end date | 2020-07-30 |
| Shortage status | Resolved |
| Updated date | 2020-07-31 |
| Company comments | Limited product supply is available on allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13 DUBLIN, -- IRELAND D13R20R |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-07-22 | English | Compare |
| v2 | 2020-07-22 | French | Compare |
| v3 | 2020-07-30 | English | Compare |
| v4 | 2020-07-30 | English | Compare |
| v5 | 2020-07-30 | French | Compare |
| v6 | 2020-07-31 | English | Compare |
Showing 1 to 6 of 6